Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Cirmtuzumab + Paclitaxel
Sponsor: Barbara Parker, MD
Collaborators: Oncternal Therapeutics, Inc